Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Prenetics Global Ltd

$20.00 +0.70% NASDAQ: PRE · 15-min delayed
  • Public · NASDAQ: PRE
  • 98 employees
$337.6MMarket cap
98Employees
PRENASDAQ
2022IPO

About Prenetics Global Ltd

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$337.6M
Gross margin
16.5%
Operating margin
3.3%
Net margin
2.0%
Multi-year

Revenue & profit trend

Revenue Net income
FY 2015

Financial statements

Income statement

Revenue
$5.4B
Cost of revenue
$4.5B
Gross profit
$895.0M
Operating expenses
$714.6M
Operating income
$180.4M
Income tax
$79.7M
Net income
$107.2M
EPS (basic)
$1.00
EPS (diluted)
$0.97

Balance sheet

Total assets
$21.4B
Current assets
$21.4B
Total liabilities
$14.5B
Current liabilities
$14.5B
Shareholders’ equity
$6.9B

Cash flow

Operating cash flow
$318.8M
Investing cash flow
$295.3M
Financing cash flow
-$309.5M
Net cash flow
$263.6M

Statements via Polygon.io (SEC filings)

NASDAQ: PRE
$20.00 +0.70%

15-minute delayed · data by Polygon.io

Past year

$5.19 $22.15

52-week range

Market cap
$337.6M
P/E ratio
20.6
EPS (diluted)
$0.97
Shares outstanding
16.9M
Open
Day range
Prev close
Volume
IPO date
May 18, 2022

Market data by Polygon.io · prices are 15-minute delayed

Auto-generated

At a glance

  • Revenue grew 1% from FY2011 to FY2015.
  • Gross margin of 16.5%, net margin 2.0%.
  • Trading 10% below its 52-week high.
  • Valued at a price-to-earnings (P/E) ratio of 20.6.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Prenetics Global Ltd.

Write a review
Newsroom

News about Prenetics Global Ltd

News & sentiment via Polygon.io

Explore

Similar companies

Browse all →